Featured
Read our handpicked blogs, curated for you.
|
The risk landscape for global finance has moved beyond simple predictive modeling. For years, AI for risk management in…
|
The landscape of financial crime has entered a new era of technical sophistication. For years, AI for fraud detection…
|
The Evolution of Banking Data QualityThe first generation of banking data quality tools relied on rigid, rules-based…
Recent releases
|
Pharma Content Engines Why PowerPoint and Agencies Are No Longer Enough
Every pharma CMO knows the routine. A brand team needs new content. An agency is briefed, a PowerPoint deck is created, and then the MLR process drags for weeks. By the time it’s approved, the…
|
Next Best Action Artificial Intelligence in Pharma Separating Hype from Real Outcomes
Everywhere you turn, someone is pitching artificial intelligence in pharma as the future. Vendors promise predictive insights, automated engagement, and “next best action” recommendations that will…
|
The Pharma ROI Black Hole Why Spends Crores Without Knowing What Works
The problem no one wants to admit is that every year, Indian pharma companies spend crores on marketing- reps, conferences, digital campaigns, agencies. Yet when boards ask the simplest question-…
|
Content Velocity in Pharma: Why Speed is the New Compliance
Content Velocity in Pharma has quietly become the metric that separates companies who talk about digital transformation from those who execute it. Indian pharma firms are spending heavily on…
